Report ID : CBI_1072 |
Base Year: | 2022 |
---|---|
CAGR: | 5.1% |
Forecast Year: | 2023 - 2030 |
Revenue 2022: | $18,593.69 Mn |
Revenue 2030: | $27,657.78 Mn |
Consegic Business Intelligence analyzes that the Bone Harvester market is growing with a CAGR of 5.1% during the forecast period (2023-2030), and the market is projected to be valued at 27,657.78 Million by 2030 from 18,593.69 Million in 2022.
The bone harvester typically consists of a handle and a hollow tube with sharp cutting edges that are used to efficiently obtain bone grafts from the patient's body. Such a type of graft provides structural support and enhances bone healing. The common types of bone grafting performed in hospitals include autograft, allograft, and synthetic bone grafting. A bone graft is a surgical procedure used to replace the damaged bones. Bone grafts are indicated for a range of orthopedic aberrations such as non-unions, delayed unions, comminuted fractures, bone disorders, and congenital diseases.
The increasing cases of bone fractures due to sports injuries, car accidents, and trauma injuries result in bone defects which drives the demand for bone harvesting. A bone harvester is a medical device used in orthopedic surgery to harvest bone grafts from a patient's body. Bone grafts are used as a filler and scaffold to facilitate bone formation and promote wound healing. These grafts are bioresorbable and act as a mineral reservoir that induces new bone formation by using a bone harvester.
For instance, according to the scientific report published by Springer Nature Limited in April 2022, a total of 67,249 patients were admitted to hospitals in China with 68,989 fractures. The highest proportion of fractures was in the tibia and fibula (14.9%), followed by the femur (13.6%) and ulna and radius (12.5%). Hence, the increasing cases of bone fractures due to accidents and trauma injuries are driving the need for bone grafting, in turn, increasing the growth of the bone harvester market.
The increasing cases of bone disorders such as osteoporosis, arthritis, osteomalacia (rickets), and hyperparathyroidism are resulting in weakened bone, loss of bone, or delayed bone growth. Such type of bone disorders widely requires orthopedic surgeries. For instance, osteoporosis is a bone disease that develops when bone mineral density and bone mass decrease, or the structure and strength of bone change. Such a type of disorder requires bone grafting surgeries. Bone grafting is a surgical procedure that uses the transplanted bone to repair and rebuild diseased or damaged bone using a medical device known as a bone harvester. Bone harvesters are used to obtain bone grafts efficiently for successful grafting surgeries.
For instance, according to the statistics published by the International Osteoporosis Foundation, 1 in 3 women over the age of 50 years and 1 in 5 men over the age of 50 years, worldwide, are suffering from osteoporosis. Hence, the increasing cases of bone disorders require the need for bone harvesting which is further driving the growth of the market.
Orthopedic surgeries require bone harvesting systems that provide surgeons with an efficient way to recover autogenous bone from various harvest sites. However, the high costs associated with orthopedic surgeries, bone transplants, and the expensive devices that are required for bone grafting act as key factors in hampering the growth of the bone harvester market. For instance, according to the statistics published by the National Library of Medicine, the most popular synthetic ceramics used in bone surgeries are Mastergraft and Vitoss which together, comprised more than half of the bone graft substitute market. In cases where synthetic grafts were used, surgeons applied an average of 12.7 mL of graft at an average price of approximately USD 1,100 per case. Hence, this high cost of synthetic grafts is likely to limit the market growth.
The advancement in technology provides opportunities to the key players for the manufacturing of advanced bone harvesters that are anticipated to obtain high-quality autografts and offer minimally invasive surgery to patients and are more efficient in terms of bone harvesting than standard devices. For instance, Avitus Orthopaedics, a medical device company, introduced the Avitus Bone Harvester - 6mm Edition. This device is an excellent option for surgeons to harvest small to large volumes of autologous bone graft and marrow from smaller bone anatomies such as the calcaneus and distal radius. The new bone harvester also features a 30% smaller pilot hole entry than the standard edition. Hence, the increasing development of advanced bone harvester devices is expected to drive the growth of the market during the forecast period.
Report Attributes | Report Details |
Study Timeline | 2017-2030 |
Market Size in 2030 | USD 27,657.78 Million |
CAGR (2023-2030) | 5.1% |
By Method | Cancellous Bone Harvesting, Bone Marrow Aspirate, and Otherss |
By Application | Fractures, Fusion, Bone Repair, and Others |
By Surgery Type | Open Surgery, Minimally-Invasive Surgery, and Others |
By End User | Hospitals, Ambulatory Surgery Centres, Diagnostic Centres, and Others |
By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Players | Acumed LLC, Globus Medical, Arthrex, Inc., Paragon 28, Inc., Conmed Corporation, Paradigm Biodevices Inc., Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Avitus Orthopaedics, Trinity Orthopedics, Wright Medical Group N.V., Stryker, and Biogennix, LLC. |
Get More Information
Download Sample ReportThe method segment is categorized into cancellous bone harvesting, bone marrow aspirate, and others. In 2022, the bone marrow aspirate segment accounted for the highest market share of 43.50% in the overall bone harvester market and is expected to grow at the fastest CAGR during the forecast period. In a bone marrow aspiration, a thin needle is used to remove a small amount of liquid bone marrow, usually from the pelvis. Bone marrow aspiration ensures the bone marrow is healthy and produces a normal amount of blood cells. Such type of a method is used to diagnose several conditions including anemia, blood cell conditions, and blood cancer, among others. For instance, according to the statistics published by the National Cancer Institute, in 2020, an estimated 490,875 people were living with leukemia (blood cancer) in the U.S. Hence, this increasing prevalence of blood cancer is expected to proliferate the growth of bone marrow aspiration and marrow biopsy for diagnosis and monitoring of blood diseases.
Get More Information
Download Sample ReportThe application segment is divided into fractures, fusion, bone repair, and others. In 2022, the bone repair segment accounted for the highest market share in the bone harvester market. Osteoarthritis is a degenerative disease resulting in chronic pain. Osteoarthritis can degrade cartilage, cause inflammation, and change bone shape resulting in stiffness, pain, and loss of mobility. Such type of bone disorders results in bone repair. Bone grafts are considered the gold standard for bone repair because they have excellent biocompatibility and potential for bone regeneration.
For instance, according to the Osteoarthritis (OA) Action Alliance, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million adults in the U.S. and 62% of individuals with osteoarthritis are women. Hence, the rising cases of osteoarthritis are driving the need for bone repair which is further increasing the market growth.
However, the bone fracture segment is expected to grow at the fastest CAGR over the forecast period. A bone fracture occurs due to the minimal trauma injury resulting from certain medical conditions that weaken the bones such as osteoporosis, osteopenia, osteopenia, and bone cancer. The rising prevalence of such bone disorders is expected to increase the demand for bone harvesters to perform efficient orthopedic surgery to repair and rebuild diseased or damaged bones.
The surgery type segment is categorized into open surgery, minimally-invasive surgery, and others. In 2022, the open surgery segment accounted for the largest market share in the bone harvester market. Open surgery requires a sufficient length of incision to allow the surgeon to place retractors and visualize the bone. Such type of surgery has a few disadvantages such as longer recovery time, lengthy incisions and retraction, and high complication rates.
However, the minimally invasive surgery segment is expected to grow at the fastest CAGR over the forecast period. Minimally invasive is a laparoscopic surgery that involves multiple small incisions to perform a surgical procedure. These smaller incisions offer benefits such as a lower risk of bleeding and decreased infection rates compared to open surgery. For instance, Trinity Orthopedics launched COREX a revolutionary, minimally invasive bone harvester made to simplify and streamline the harvesting process. Such types of devices allow for reduced operative time, efficient cancellous bone extraction, and zero infection rates which are the key factor expected to drive the market growth.
The end-user segment is classified into hospitals, ambulatory surgery centers, diagnostic centers, and others. In 2022, the hospital segment accounted for the highest market share and is also expected to grow at the fastest CAGR over the forecast period. This is due to the rising cases of accidents resulting in increasing bone fractures and the increasing prevalence of osteoporotic fractures among postmenopausal females. Such type of bone fractures requires brane grafting. A bone harvester is a medical device used to obtain bone grafts from a patient's own body. The rising adoption of advanced bone harvesters in hospitals for autogenous bone grafting is driving the market growth.
For instance, according to the statistics published in the National Library of Medicine, the overall prevalence of osteoporotic fractures among postmenopausal females was 82.2% out of which 37.5% were osteoporosis and 44.7% were osteopenia. This increasing prevalence of bone fractures is driving the demand for bone harvesting or grafting, in turn, driving the growth of the bone harvester market.
The regional segment includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regional Growth Insights
Download Sample ReportIn 2022, North America accounted for the highest market share at 37.45% and was valued at USD 6,963.34 million, which is expected to reach USD 10,393.79 million in 2030. In North America, the U.S. accounted for the highest market share of 65.35% during the base year 2022 owing to the increasing incidences of orthopedic disorders and surgeries in the U.S.
Further, the market players in the region are involved in mergers and acquisitions, product innovations, and business strategies to cater to the growing needs of various end-use industries by offering advanced medical devices. For instance, in November 2019, Wright Medical Group Inc., a global medical device company was acquired by Stryker Company. This acquisition is expected to offer advanced medical devices in the orthopedics segment.
Moreover, Asia Pacific is expected to grow at the fastest CAGR of 6.2% during the forecast period due to the growing government investment in the development of advanced medical devices, the rising patient population, and new hospital facilities particularly in China and India.
Details Countries Growth Insights
Download Sample ReportThe bone harvester market is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships. The key players in the market include-
In 2022, the market size of bone harvester was USD 18,593.69 million.
In 2030, the market size of bone harvester will be expected to reach USD 27,657.78 million.
Rising cases of bone fracture and the increasing prevalence of bone disorders are the key factors driving the growth of the bone harvester market.
In 2022, the bone marrow aspirate segment accounted for the highest market share of 43.50% in the overall bone harvester market.
Asia Pacific is expected to be the fastest-growing region in the market during the forecast period.